Recently, fenfluramine appetite suppressants became widely used in the United States but were withdrawn in September 1997 because of concerns over adverse effects. Materials and methods ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Losing weight on a GLP-1 medication can have emotional and physical effects. Some changes are easier to handle than others, ...

DelveInsight's“Lennox–Gastaut syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lennox–Gastaut syndrome, historical and forecasted ...

For Carol Gordon, weight loss has been a lifelong mission. Back in the 1990s, she took fen-phen, the combination of fenfluramine and phentermine that produced the marked weight loss we now expect ...